vs

Side-by-side financial comparison of TPG Mortgage Investment Trust, Inc. (MITT) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.

TPG Mortgage Investment Trust, Inc. is the larger business by last-quarter revenue ($20.4M vs $13.3M, roughly 1.5× OCULAR THERAPEUTIX, INC). TPG Mortgage Investment Trust, Inc. runs the higher net margin — 65.0% vs -488.0%, a 552.9% gap on every dollar of revenue. On growth, TPG Mortgage Investment Trust, Inc. posted the faster year-over-year revenue change (17.7% vs -22.4%). Over the past eight quarters, TPG Mortgage Investment Trust, Inc.'s revenue compounded faster (9.1% CAGR vs -5.3%).

TPG Mortgage Investment Trust, Inc. is a real estate investment trust managed by global alternative asset firm TPG. It primarily invests in residential and commercial mortgage-backed securities, performing and non-performing mortgage loans, and other credit-linked real estate assets, with its core market being the United States. It generates returns via net interest income from holdings and strategic asset disposition gains.

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

MITT vs OCUL — Head-to-Head

Bigger by revenue
MITT
MITT
1.5× larger
MITT
$20.4M
$13.3M
OCUL
Growing faster (revenue YoY)
MITT
MITT
+40.1% gap
MITT
17.7%
-22.4%
OCUL
Higher net margin
MITT
MITT
552.9% more per $
MITT
65.0%
-488.0%
OCUL
Faster 2-yr revenue CAGR
MITT
MITT
Annualised
MITT
9.1%
-5.3%
OCUL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MITT
MITT
OCUL
OCUL
Revenue
$20.4M
$13.3M
Net Profit
$13.3M
$-64.7M
Gross Margin
88.0%
Operating Margin
67.1%
-526.5%
Net Margin
65.0%
-488.0%
Revenue YoY
17.7%
-22.4%
Net Profit YoY
-7.0%
-33.6%
EPS (diluted)
$0.27
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MITT
MITT
OCUL
OCUL
Q4 25
$20.4M
$13.3M
Q3 25
$19.5M
$14.5M
Q2 25
$17.8M
$13.5M
Q1 25
$18.8M
$10.7M
Q4 24
$17.4M
$17.1M
Q3 24
$14.9M
$15.4M
Q2 24
$16.4M
$16.4M
Q1 24
$17.2M
$14.8M
Net Profit
MITT
MITT
OCUL
OCUL
Q4 25
$13.3M
$-64.7M
Q3 25
$20.0M
$-69.4M
Q2 25
$3.9M
$-67.8M
Q1 25
$11.5M
$-64.1M
Q4 24
$14.3M
$-48.4M
Q3 24
$16.6M
$-36.5M
Q2 24
$3.9M
$-43.8M
Q1 24
$20.9M
$-64.8M
Gross Margin
MITT
MITT
OCUL
OCUL
Q4 25
88.0%
Q3 25
87.8%
Q2 25
85.6%
Q1 25
88.2%
Q4 24
92.8%
Q3 24
89.9%
Q2 24
90.8%
Q1 24
91.0%
Operating Margin
MITT
MITT
OCUL
OCUL
Q4 25
67.1%
-526.5%
Q3 25
-472.3%
Q2 25
20.9%
-502.6%
Q1 25
54.6%
-597.5%
Q4 24
76.7%
-296.1%
Q3 24
-298.2%
Q2 24
18.4%
-265.1%
Q1 24
-214.0%
Net Margin
MITT
MITT
OCUL
OCUL
Q4 25
65.0%
-488.0%
Q3 25
102.5%
-477.3%
Q2 25
22.2%
-503.9%
Q1 25
60.9%
-598.7%
Q4 24
82.2%
-283.3%
Q3 24
111.3%
-236.6%
Q2 24
24.0%
-266.3%
Q1 24
121.6%
-438.9%
EPS (diluted)
MITT
MITT
OCUL
OCUL
Q4 25
$0.27
$-0.27
Q3 25
$0.47
$-0.38
Q2 25
$-0.05
$-0.39
Q1 25
$0.21
$-0.38
Q4 24
$0.30
$-0.25
Q3 24
$0.40
$-0.22
Q2 24
$-0.02
$-0.26
Q1 24
$0.55
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MITT
MITT
OCUL
OCUL
Cash + ST InvestmentsLiquidity on hand
$57.8M
$737.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$560.7M
$654.3M
Total Assets
$8.7B
$808.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MITT
MITT
OCUL
OCUL
Q4 25
$57.8M
$737.1M
Q3 25
$59.0M
$344.8M
Q2 25
$88.7M
$391.1M
Q1 25
$115.5M
$349.7M
Q4 24
$118.7M
$392.1M
Q3 24
$102.5M
$427.2M
Q2 24
$120.9M
$459.7M
Q1 24
$100.3M
$482.9M
Stockholders' Equity
MITT
MITT
OCUL
OCUL
Q4 25
$560.7M
$654.3M
Q3 25
$559.8M
$258.2M
Q2 25
$536.4M
$305.9M
Q1 25
$543.9M
$265.9M
Q4 24
$543.4M
$315.3M
Q3 24
$540.1M
$352.0M
Q2 24
$533.5M
$377.7M
Q1 24
$539.6M
$408.0M
Total Assets
MITT
MITT
OCUL
OCUL
Q4 25
$8.7B
$808.1M
Q3 25
$9.0B
$410.9M
Q2 25
$7.5B
$451.3M
Q1 25
$7.3B
$405.9M
Q4 24
$6.9B
$457.9M
Q3 24
$7.0B
$490.4M
Q2 24
$7.1B
$517.1M
Q1 24
$6.4B
$538.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MITT
MITT
OCUL
OCUL
Operating Cash FlowLast quarter
$59.6M
$-54.2M
Free Cash FlowOCF − Capex
$-57.1M
FCF MarginFCF / Revenue
-430.9%
Capex IntensityCapex / Revenue
21.4%
Cash ConversionOCF / Net Profit
4.48×
TTM Free Cash FlowTrailing 4 quarters
$-216.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MITT
MITT
OCUL
OCUL
Q4 25
$59.6M
$-54.2M
Q3 25
$17.4M
$-50.7M
Q2 25
$11.5M
$-55.2M
Q1 25
$12.0M
$-44.7M
Q4 24
$55.8M
$-39.4M
Q3 24
$14.5M
$-36.6M
Q2 24
$13.7M
$-24.8M
Q1 24
$12.0M
$-33.9M
Free Cash Flow
MITT
MITT
OCUL
OCUL
Q4 25
$-57.1M
Q3 25
$-56.7M
Q2 25
$-56.5M
Q1 25
$-46.6M
Q4 24
$-39.6M
Q3 24
$-36.6M
Q2 24
$-25.5M
Q1 24
$-34.1M
FCF Margin
MITT
MITT
OCUL
OCUL
Q4 25
-430.9%
Q3 25
-390.0%
Q2 25
-419.7%
Q1 25
-435.6%
Q4 24
-232.0%
Q3 24
-237.6%
Q2 24
-155.4%
Q1 24
-231.1%
Capex Intensity
MITT
MITT
OCUL
OCUL
Q4 25
21.4%
Q3 25
41.2%
Q2 25
9.3%
Q1 25
18.1%
Q4 24
1.2%
Q3 24
0.6%
Q2 24
4.5%
Q1 24
1.7%
Cash Conversion
MITT
MITT
OCUL
OCUL
Q4 25
4.48×
Q3 25
0.87×
Q2 25
2.92×
Q1 25
1.05×
Q4 24
3.91×
Q3 24
0.87×
Q2 24
3.50×
Q1 24
0.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons